Category Archives: Pharmaceuticals & Biotech
HER2-Negative Breast Cancer – Pipeline Insight, 2026 There are 70+ key companies, including Merck Sharp & Dohme LLC, AstraZeneca, Roche, Genentech, Daiichi Sankyo, Novartis, Beijing Biotech, and Regor Therapeutics, developing therapies for HER2-Negative Breast Cancer, with AstraZeneca leading with advanced … Continue reading
Endometrial Cancer – Pipeline Insight, 2026 There are over 50 key companies, including Karyopharm Therapeutics, Eli Lilly, Netris Pharma, Incyte Corporation, and others, developing therapies for Endometrial Cancer, with several candidates now in advanced Phase III and Phase II stages … Continue reading
Treatment Resistant Depression (TRD) – Pipeline Insight, 2026 There are 25+ key companies, including Janssen Pharmaceuticals, Merck, Novartis, Sage Therapeutics, Axsome Therapeutics, and COMPASS Pathways, developing therapies for Treatment Resistant Depression, with several novel-mechanism drugs currently in Phase III clinical … Continue reading
Clostridium Difficile Infections Clinical Trial Key Clostridium Difficile Infections Companies are Acurx Pharmaceuticals, Adiso Therapeutics, Summit Therapeutics, Finch Therapeutics, Vedanta Biosciences, and others. Clostridium Difficile Infections (CDI) therapeutics are entering a new era of innovation and clinical acceleration, driven by … Continue reading
Non-Cystic Fibrosis Bronchiectasis Clinical Trials Key Non-Cystic Fibrosis Bronchiectasis Companies are Zambon SpA, Insmed Incorporated, NovaBiotics, Haisco Pharmaceutical Group, Armata Pharmaceuticals, Chiesi Farmaceutici, CSL Behring, and others. The Non-Cystic Fibrosis Bronchiectasis (NCFB) therapeutic landscape is witnessing a strong wave of … Continue reading
Diabetic Retinopathy Clinical Trial Key Diabetic Retinopathy Companies are Kodiak Sciences, RemeGen, Vantage Biosciences Ltd, Apexian Pharmaceuticals, Ocular Therapeutix, Regenxbio, Adverum Biotechnologies, Therini Bio Pty Ltd, and others The Diabetic Retinopathy therapeutic landscape is undergoing a significant evolution, driven by … Continue reading
Huntington’s Disease Clinical Trial Key Huntington’s Disease Companies are Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG Bio, and others. Huntington’s Disease Pipeline Set for Breakthrough Transformation by 2026 with 20+ Therapies and Advancing Gene-Silencing Innovations from Hoffmann-La Roche, … Continue reading
DelveInsight’s, “Oncolytic Virus Cancer Therapy Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 125+ pipeline drugs in Oncolytic Virus Cancer Therapy pipeline landscape. It covers the Oncolytic Virus Cancer Therapy pipeline drug profiles, including clinical and non-clinical … Continue reading
DelveInsight’s, “Hypertension Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics … Continue reading
DelveInsight’s “JAK Inhibitor Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the JAK Inhibitor pipeline landscape. It covers the JAK Inhibitor pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
